Genzyme Ready To Launch Fabrazyme And Aldurazyme; User Fee Dates Near
Executive Summary
Genzyme is ready to launch both Fabrazyme and Aldurazyme simultaneously if FDA approvals come through in April, the company says
You may also be interested in...
Genzyme Aldurazyme Patient Registry Will Evaluate AEs, Antibody Formation
BioMarin/Genzyme will develop an Aldurazyme patient registry to evaluate the long-term safety and activity of the product
Genzyme Aldurazyme Patient Registry Will Evaluate AEs, Antibody Formation
BioMarin/Genzyme will develop an Aldurazyme patient registry to evaluate the long-term safety and activity of the product
Fabrazyme Approved; FDA Weighing What Confirmatory Data Will Be Needed
FDA has set a deadline of Jan. 31, 2004 for Genzyme's Fabrazyme confirmatory placebo-controlled trial following its April 24 approval